Se III, randomized, doubleblind trials evaluating the safety and efficacy of
Se III, randomized, doubleblind trials evaluating the safety and efficacy of TAF versus TDF for the therapy of chronic HBV infection have been released. The trials enrolled each treatmentnaive and…